Aubin Michalon

USPTO Granted Patents = 3 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 4(Granted Patents)

Company Filing History:

3 out of 16

Neurimmune Holding Ag

patents

Years Active: 2019-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12234281 - Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor (2025-02-25),

2. 11180545 - Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor (2021-11-23),

3. 10344080 - Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor (2019-07-09),

Title: Inventor Aubin Michalon

Introduction: Aubin Michalon is a renowned inventor based in Baden, Switzerland, known for his groundbreaking contributions to various technological fields.

Latest Patents: Aubin Michalon holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials.

Career Highlights: Throughout his career, Aubin Michalon has been instrumental in developing innovative solutions for clean energy production and eco-friendly transportation systems. His work has significantly impacted the way we approach sustainability in modern society.

Collaborations: Aubin Michalon has collaborated with leading research institutions and universities worldwide to further his research and bring his inventions to life. His partnerships have been crucial in pushing the boundaries of technological advancements.

Conclusion: Aubin Michalon's dedication to creating sustainable technologies and his passion for innovation make him a key figure in the world of inventors. His work continues to inspire future generations to think creatively and develop solutions for a more sustainable future.

This text is generated by artificial intelligence and may not be accurate.